Hi Cgt2009,
Of course this is all speculation right now but here is my best guess and speculation:
This might involve the sale of a fair chunk if not the majority of our stake in the Vax business.
It may not be big Pharma.
I think any money received from that sale will be available for Admedus Limited (Med Tech company) to redeploy into Adapt business growth.
This is all speculation and it will be interesting to see what actually happens.
IMHO - We should never really have been in Immunotherapies and we will be a much better company when we no longer need to worry about it. If we retain some possible upside without the associated funding costs that would be perfect. We can move forward with some money in hand and develop/grow our Adapt and 3D business.
Not advice and DYOR
- Forums
- ASX - By Stock
- AVR
- Upcoming Immunotherapies Deal (???)
Upcoming Immunotherapies Deal (???), page-2
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M |
Open | High | Low | Value | Volume |
$18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $18.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.69 | 53 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 18.400 |
1 | 1000 | 16.000 |
1 | 198 | 15.150 |
1 | 1000 | 14.950 |
1 | 219 | 13.670 |
Price($) | Vol. | No. |
---|---|---|
18.690 | 53 | 1 |
18.800 | 258 | 1 |
18.900 | 500 | 1 |
18.910 | 100 | 1 |
19.500 | 21 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online